MEDX Oncology West


Session 9: Patient-Centered Care for Genitourinary Cancers

Saturday, November 18     11:30am – 12:30pm

Description

The rising disparities in access to and costs of cancer care necessitate a personalized approach to improve quality. The focus on high-value care has been centered on the reduction of unnecessary tests and procedures; however, oncologists have an opportunity to reduce ineffective treatment recommendations for patients with genitourinary (GU) cancers. This approach, when consistent with evidence-based guidelines, can reduce costs and improve patient outcomes. The challenge remains for community clinicians to utilize clinical guidelines while staying up to date with a plethora of new data that can further refine the treatment of patients with prostate cancer and renal cell cancer.

Session Outline

Faculty will discuss 2 patient stories to highlight the factors that impact treatment decisions in GU cancers. The presentation will be interactive featuring the use of iPads throughout the session. The following areas will be discussed:

  • Case 1: A patient with mCRPC with/without visceral metastases
    • Diagnosis and surveillance and resistance markers
    • Response to prior therapies
    • Approved agents and clinical guidelines on systemic therapy
    • Safety and efficacy of emerging agents and combinations
  • Case 2: A patient with advanced/metastatic RCC
    • The role of biomarkers
    • Clinical guidelines, refining treatment selection
    • Approved treatment options for progressive disease
    • Emerging efficacy and safety data from clinical trials of novel agents and combinations

Q&A Session and Presentation Roundup

CME Information

AMA PRA Category 1 Credits™

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe Oncology. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

The Potomac Center for Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ANCC

Elsevier is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Elsevier is provider approved by the Florida Board of Nursing, Provider #50-4681, and the California Board of Registered Nursing, Provider #CEP 3257.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the EOCME, Elsevier’s accredited Provider Unit, and Rockpointe Oncology. Elsevier designates this activity for 1.0 CNE credits.

ACPE

Pharmacists – The Potomac Center for Medical Education is accredited by the Accreditation Council for Pharmacy education as a provider of continuing pharmacy education.

The Potomac Center for Medical Education designates this educational activity for a maximum of 1.0 hour (0.10 CEUs) of continuing education credit (UAN: xxx).

This is an application-based activity.

Faculty Information

Coming Soon